Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Aprepitant for Pediatric CINV
NCT02097823Phase 2Completed
- Sponsor
- Indiana University
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Indiana University. Primary endpoint: Feasibility of Recruitment and Data Collection at 1 year. Started Feb 2014; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02097823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097823.